The approval of TEPOXX in Japan marks another significant milestone in our mission to expand access to this critical ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

John Boadu, Director General (DG) of the State Interests and Governance Authority (SIGA), has called on the incoming ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

(RTTNews) - SIGA Technologies, Inc. (SIGA), Thursday announced that its tecovirimat 200 mg capsules, traded as TEPOXX, has secured regulatory approval in Japan for the treatment of smallpox, mpox, ...

The antiviral drug tecovirimat, from Siga Technologies (SIGA), did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate clade II mpox and a low ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Siga Technologies Inc. (SIGA) have been struggling lately and have lost 9% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...

SIGA Technologies has gained Japanese regulatory approval for TEPOXX (tecovirimat) 200mg capsules, known as TPOXX in the US, for the treatment of smallpox, mpox and cowpox, and complications ...